Suchergebnisse - "Halpin, David M G"

PubPharm (8)

1

A Response to : Letter to the Editor Regarding "Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis"

enthalten in: Advances in therapy | 2023

von Ismaila, A. | Haeussler, K. | Malmenäs, M. | +5

CommentOn: Adv Ther. 2022 Sep;39(9):3957-3978. - PMID 35849317

2

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease : A Network Meta-Analysis

enthalten in: Advances in therapy | 2022

von Ismaila, A. | Haeussler, K. | Czira, A. | +11

ErratumIn: Adv Ther. 2022 Sep 2;:. - PMID 36056291

3

Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD : A Network Meta-Analysis

enthalten in: Advances in therapy | 2022

von Ismaila, A. | Haeussler, K. | Czira, A. | +10

CommentIn: Adv Ther. 2023 May;40(5):2549-2555. - PMID 37004641

4

Single-Inhaler Triple Therapy in Patients with Advanced COPD : Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial

enthalten in: International journal of chronic obstructive pulmonary disease | 2022

von Gabrio, A. | Gunsoy, N. | Baio, G. | +12

5

Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD : A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial

enthalten in: Chest | 2021

von Hanania, N. | Mannino, D. | Criner, G. | +12

CommentIn: Chest. 2021 Mar;159(3):895-896. - PMID 33678268

6

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD : The IMPACT Study

enthalten in: Advances in therapy | 2020

von Tabberer, M. | Jones, C. | Kilbride, S. | +12

ErratumIn: Adv Ther. 2022 Mar;39(3):1446. - PMID 35060093

7

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

enthalten in: American journal of respiratory and critical care medicine | 2020

von Lipson, D. | Crim, C. | Criner, G. | +17

CommentIn: Am J Respir Crit Care Med. 2020 Jun 15;201(12):1463-1464. - PMID 32212973

8

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD : results on cardiovascular safety from the IMPACT trial

enthalten in: Respiratory research | 2020

von Day, N. | Kumar, S. | Criner, G. | +13

1
[1]